Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

21.87
Delayed Data
As of 4:00pm ET
 +0.04 / +0.18%
Today’s Change
9.51
Today|||52-Week Range
24.00
+62.72%
Year-to-Date
Supernus' Trokendi XR Gets FDA Nod for Migraine in Adults
Aug 22 / Zacks.com - Paid Partner Content